ABSTRACT
The World Health Organization (WHO) officially announced COVID-19 as a global pandemic in March 2020 which in effect transformed the society, economy, the politics and indeed our everyday life. Such a transformation of power geometries across all manner of spaces and their geographies disrupted the finite balance and wellbeing and continues to displace norms of equanimity, sanity, and hope amidst the catalogue of errors, blunders and inactivity. In India the first COVID-19 case was registered on January 30, 2020. The response of 29 States and 7 Union Territories of India has varied depending on their health, community, law and order and legislative infrastructure. This chapter will attempt to situate an analysis of coronavirus pandemic within the demographic transition framework of India. We examine the critical role of civil societies across the states, divergence of policies and practices relating to social distancing, contact tracing, and differential Public Health Agency infrastructures in operation across the States of India. What began as a stigma, followed by populist rhetoric quickly faded into intense struggle for survival even as oxygen, essential medicines and of course hospital beds became a premium in the most affluent parts of any given city. The grim reaper became a great leveller cutting across socially constructed boundaries of class, gender, age, caste and religion. The management of this pandemic and the established protocols for treatment remain tentative even as we learn lessons from yet another mutant strain. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.
ABSTRACT
The publication of this article unfortunately contained mistakes. The funding note was not correct. The corrected funding note is given below. Funding The current study was funded by;The National Key Research and Development Program of China [Grant No. 2019QY(Y)0502];The Key Research and Development Program of Shaanxi Province [Grant No. 2020ZDLSF04- 07];The National Natural Science Foundation of China [Grant No. 51905438];The Fundamental Research Funds for the Central Universities [Grant No. 31020190502009];The Innovation Platform of Bio fabrication [Grant No. 17SF0002];and China postdoctoral Science Foundation [Grant No. 2020M673471]. The original article has been corrected. © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023.
ABSTRACT
INTRODUCTION: Supplementary immunization activities (SIAs) aim to interrupt measles transmission by reaching susceptible children, including children who have not received the recommended two routine doses of MCV before the SIA. However, both strategies may miss the same children if vaccine doses are highly correlated. How well SIAs reach children missed by routine immunization is a key metric in assessing the added value of SIAs. METHODS: Children aged 9 months to younger than 5 years were enrolled in cross-sectional household serosurveys conducted in five districts in India following the 2017-2019 measles-rubella (MR) SIA. History of measles containing vaccine (MCV) through routine services or SIA was obtained from documents and verbal recall. Receipt of a first or second MCV dose during the SIA was categorized as "added value" of the SIA in reaching un- and under-vaccinated children. RESULTS: A total of 1,675 children were enrolled in these post-SIA surveys. The percentage of children receiving a 1st or 2nd dose through the SIA ranged from 12.8% in Thiruvananthapuram District to 48.6% in Dibrugarh District. Although the number of zero-dose children prior to the SIA was small in most sites, the proportion reached by the SIA ranged from 45.8% in Thiruvananthapuram District to 94.9% in Dibrugarh District. Fewer than 7% of children remained measles zero-dose after the MR SIA (range: 1.1-6.4%) compared to up to 28% before the SIA (range: 7.3-28.1%). DISCUSSION: We demonstrated the MR SIA provided considerable added value in terms of measles vaccination coverage, although there was variability across districts due to differences in routine and SIA coverage, and which children were reached by the SIA. Metrics evaluating the added value of an SIA can help to inform the design of vaccination strategies to better reach zero-dose or undervaccinated children.